首页> 外文OA文献 >Case study: Ticagrelor in plato and prasugrel in triton-timi 38 and trilogy-acs trials in patients with acute coronary syndromes

【2h】

Case study: Ticagrelor in plato and prasugrel in triton-timi 38 and trilogy-acs trials in patients with acute coronary syndromes

机译：案例研究：Triton-timi 38中普拉卡格雷和普拉格雷中的替卡格雷用于急性冠脉综合征患者的三部曲和acs试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

textabstractCopyright

著录项

作者
Husted, S.; Boersma, Eric;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种 en
中图分类

相似文献

外文文献
中文文献
专利

1. Case Study: Ticagrelor in PLATO and Prasugrel in TRITON-TIMI 38 and TRILOGY-ACS Trials in Patients With Acute Coronary Syndromes [J] . Husted Steen, Boersma Eric American journal of therapeutics . 2016,第6期

机译：案例研究：急性冠脉综合征患者的PLATO中的替加格雷洛和TRITON-TIMI 38中的普拉格雷和TRILOGY-ACS试验
2. Case Study: Ticagrelor in PLATO and Prasugrel in TRITON-TIMI 38 and TRILOGY-ACS Trials in Patients With Acute Coronary Syndromes [J] . Husted Steen, Boersma Eric American journal of therapeutics . 2016,第6期

机译：案例研究：TicagreloL在Triton-Timi 38中的普拉沙拉和急性冠状动脉综合征患者的Trilogy-ACS试验
3. Discharge aspirin dose and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel: An analysis from the TRITON-TIMI 38 study (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38) [J] . KohliP., UdellJ.A., MurphyS.A., Journal of the American College of Cardiology . 2014,第3期

机译：普拉格雷与氯吡格雷治疗的急性冠脉综合征患者的阿司匹林剂量和临床结局：TRITON-TIMI 38研究的一项分析（尝试通过普拉格雷-溶栓治疗对心肌梗塞38进行血小板抑制优化来评估治疗效果的改善）
4. Once-daily Nadroparin Versus Twice-daily Nadroparin in the Treatment of Patients with Acute Coronary Syndromes: The SAFRAX Study [C] . V. Hricak, A. Leizorovic International Congress on Thrombosis . 2006

机译：每日一日奈多林与每次每日Nadroparin治疗患者急性冠状动脉综合征患者：Safrax研究
5. Clarifying the Optimal Management Strategy for Patients with Possible Acute Coronary Syndrome with Intermediate Stenosis and High-Risk Plaque Morphology on Coronary Computed Tomographic Angiography [D] . Dwyer, Stephanie M. 2019

机译：明确可能的急性冠脉综合征合并中度狭窄和高风险斑块形态的冠状动脉计算机断层扫描血管造影的最佳管理策略
6. Case Study: Ticagrelor in PLATO and Prasugrel in TRITON-TIMI 38 and TRILOGY-ACS Trials in Patients With Acute Coronary Syndromes [O] . Steen Husted, Eric Boersma -1

机译：案例研究：急性冠脉综合征患者的PLATO中的替卡格雷洛和TRITON-TIMI 38中的普拉格雷和TRILOGY-ACS试验
7. Letter by Damman et al Regarding Articles, "Long-Term Cardiovascular Mortality After Procedure-Related or Spontaneous Myocardial Infarction in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome: A Collaborative Analysis of Individual Patient Data From the FRISC II, ICTUS, and RITA-3 Trials (FIR)" and "American College of Cardiology/American Heart Association/European Society of Cardiology/World Heart Federation Universal Definition of Myocardial Infarction Classification System and the Risk of Cardiovascular Death: Observations From the TRITON-TIMI 38 Trial (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis in Myocardial Infarction 38)" [O] . Damman, Peter, de Winter, Robbert J., Wallentin, Lars, 2012

机译：Damman等人关于文章的信，“非ST段抬高的急性冠状动脉综合征患者与手术相关或自发性心肌梗死后的长期心血管疾病死亡率：FRISC II，ICTUS和RITA-3试验（FIR）”和“美国心脏病学会/美国心脏协会/欧洲心脏病学会/世界心脏联合会心肌梗死分类系统的普遍定义和心血管死亡的风险：来自TRITON-TIMI 38试验的观察结果（通过在心肌梗塞中使用普拉格雷-血栓溶解优化血小板抑制来评估治疗结果的改善的试验38）”

Case study: Ticagrelor in plato and prasugrel in triton-timi 38 and trilogy-acs trials in patients with acute coronary syndromes

摘要

著录项

相似文献

相关主题

期刊订阅